LI, Gang,WEI, Ge,HORNBY, Zachary D.,LIM, Jonathan Ee-Ren
申请号：
EP16876677
公开号：
EP3389645A4
申请日:
2016.12.15
申请国别(地区):
EP
年份:
2019
代理人:
摘要：
Described herein are combinations comprising a therapeutically effective amount of a first agent and a therapeutically effective amount of a second agent, wherein the first agent is an inhibitor of ALK, ROS1, TrkA, TrkB, or TrkC activity, or a combination thereof, and methods of using such combinations in the treatment of patients having cancer.
